Sign in

CIK 0001001316

  • Large accelerated filer

TG THERAPEUTICS, INC.

Sign in to watch
Ticker
TGTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363898269
Phone
+1 212-554-4484
Business address
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, 10014
Former names
MANHATTAN PHARMACEUTICALS INC, ATLANTIC TECHNOLOGY VENTURES INC, ATLANTIC PHARMACEUTICALS INC
  1. 4 Grant or award Director acquired 20,000 shares (grant or award)
  2. 4 Grant or award Director acquired 20,000 shares (grant or award)
  3. 4 Grant or award Director acquired 20,000 shares (grant or award)
  4. 4 Grant or award Director acquired 20,000 shares (grant or award)
  5. 4 Grant or award Director acquired 60,000 shares (grant or award)
  6. 5 Insider Annual Insider Trading Report
  7. 4 Grant or award CFO, Secretary and Treasurer acquired 20,000 shares (grant or award)
  8. 5 Insider Annual Insider Trading Report
  9. 4 Open-market sale Director sold 30,000 shares at $40.05 ($1,201,500)
  10. 4 Open-market sale 10% owner sold 158,589 shares at $25.81 ($4,092,738)
  11. 4 Grant or award CFO, Secretary and Treasurer acquired 250,000 shares (grant or award)
  12. 4 Grant or award Director acquired 65,000 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Grant or award CEO and President acquired 1,556,029 shares (grant or award)
  15. 4 Grant or award Director acquired 15,000 shares (grant or award)
  16. 4 Grant or award Director acquired 15,000 shares (grant or award)
  17. 4 Grant or award Director acquired 15,000 shares (grant or award)
  18. 4 Grant or award Director acquired 15,000 shares (grant or award)
  19. 4 Open-market sale Director sold 7,745 shares at $18.27 ($141,501)
  20. 3 Insider Initial Statement of Ownership

Page 4 of 18 · 353 filings